The activation sequence of cellular protein handling systems after proteasomal inhibition in dopaminergic cells

Chemico-Biological Interactions

Volumn 204, Issue 2, 2013, Pages 116-124

  Xiong, Rui ^a   Siegel, David ^a   Ross, David ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Aggresome; Autophagy; ER stress; Heat shock protein responses; Proteasome activity; UPS dysfunction

Indexed keywords

AUTOPHAGY RELATED MICROTUBULE ASSOCIATED PROTEIN 1 LIGHT CHAIN 3; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CASPASE 3; CELL PROTEIN; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; HEAT SHOCK PROTEIN 70; INITIATION FACTOR 2ALPHA; PROTEASOME; UBIQUITIN; UNCLASSIFIED DRUG; VIMENTIN;

AGGRESOME; ANIMAL CELL; ANIMAL CELL CULTURE; APOPTOSIS; ARTICLE; CELL INCLUSION; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; ENDOPLASMIC RETICULUM STRESS; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; NONHUMAN; PROTEIN ANALYSIS; PROTEIN CLEAVAGE; PROTEIN METABOLISM; PROTEIN PHOSPHORYLATION; RAT;

EUKARYOTA;

EID: 84878431591     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2013.04.016     Document Type: Article

References (57)

1. C. Soto, Unfolding the role of protein misfolding in neurodegenerative diseases, Nat. Rev. Neurosci. 4 (2003) 49-60.
2. K.S.P. McNaught, C.W. Olanow, Proteolytic stress: a unifying concept for the etiopathogenesis of Parkinson's disease, Ann. Neurol. 53 (2003) S73-S86.
3. K.S.P. McNaught, R. Belizaire, O. Isacson, P. Jenner, C.W. Olanow, Altered proteasomal function in sporadic Parkinson's disease, Exp. Neurol. 179 (2003) 38-46.
4. C.W. Olanow, Etiology and pathogenesis of Parkinson's disease, Annual Review of Neuroscience. 22 (1999) 123-144.
5. K.K.K. Chung, V.L. Dawson, T.M. Dawson, New insights into Parkinson's disease, J. Neurol. 250 (2003).
6. C.W. Olanow, Ubiquitin-proteasome system and Parkinson's disease, Mov. Disord. 21 (2006) 1806-1823.
7. K.S. Zafar, A potential role for cyclized quinones derived from dopamine, DOPA, and 3,4-dihydroxyphenylacetic acid in proteasomal inhibition, Mol. Pharmacol. 70 (2006) 1079-1086.
8. Y.Y. Jinsmaa, V.R.V. Florang, J.N.J. Rees, L.M.L. Mexas, L.L.L. Eckert, E.M.G.E. Allen, et al., Dopamine-derived biological reactive intermediates and protein modifications: implications for Parkinson's disease, Chem. Biol. Interact. 192 (2011) 118-121.
9. W. Xie, X. Li, C. Li, W. Zhu, J. Jankovic, W. Le, Proteasome inhibition modeling nigral neuron degeneration in Parkinson's disease, J. Neurochem. 115 (2010) 188-199.
10. A.C. Vernon, S.M. Johansson, Non-invasive evaluation of nigrostriatal neuropathology in a proteasome inhibitor rodent model of Parkinson's disease, BMC Neurosci. (2010).
11. S. Bukhatwa, M.M. Iravani, B.-Y. Zeng, J.D. Cooper, S. Rose, P. Jenner, An immunohistochemical and stereological analysis of PSI-induced nigral neuronal degeneration in the rat, J. Neurochem. 109 (2009) 52-59.
12. D. Ebrahimi-Fakhari, L. Wahlster, P.J. McLean, Protein degradation pathways in Parkinson's disease: curse or blessing, Acta Neuropathologica. 124 (2012) 153-172.
13. A.F. Kisselev, A.L. Goldberg, Proteasome inhibitors: from research tools to drug candidates, Chem. Biol. 8 (2001) 739-758.
14. A. Goldberg, Protein degradation and protection against misfolded or damaged proteins, Nature. 426 (2003) 895-899.
15. A.F. Kisselev, A. Callard, A.L. Goldberg, Importance of the different proteolytic sites of the proteasome and the efficacy of inhibitors varies with the protein substrate, J. Biol. Chem. 281 (2006) 8582-8590.
16. X. Zhou, T. Ikenoue, X. Chen, L. Li, K. Inoki, K.-L. Guan, Rheb controls misfolded protein metabolism by inhibiting aggresome formation and autophagy, Proc. Natl. Acad. Sci. USA 106 (2009) 8923-8928.
17. K. Ron R, Aggresomes, inclusion bodies and protein aggregation, Trends Cell Biol. 10 (2000) 524-530.
18. R. Garcia-Mata, Y.-S. Gao, E. Sztul, Hassles with taking out the garbage: aggravating aggresomes, Traffic 3 (2002) 388-396.
19. C.W. Olanow, D.P. Perl, G.N. DeMartino, K.S.P. McNaught, Lewy-body formation is an aggresome-related process: a hypothesis, Lancet Neurol. 3 (2004) 496-503.
20. H. Nishitoh, ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats, Genes Dev. 16 (2002) 1345-1355.
21. D.T. Rutkowski, R.S. Hegde, Regulation of basal cellular physiology by the homeostatic unfolded protein response, J. Cell Biol. 189 (2010) 783-794.
22. H.P. Harding, Y. Zhang, A. Bertolotti, H. Zeng, D. Ron, Perk is essential for translational regulation and cell survival during the unfolded protein response, Mol. Cell 5 (2000) 897-904.
23. W. Lin, B. Popko, Endoplasmic reticulum stress in disorders of myelinating cells, Nat. Neurosci. 12 (2009) 379-385.
24. S. Chen, I.R. Brown, Neuronal expression of constitutive heat shock proteins: implications for neurodegenerative diseases, Cell Stress Chaperones 12 (2007) 51-58.
25. B. Levine, G. Kroemer, Autophagy in the pathogenesis of disease, Cell 132 (2008) 27-42.
26. D. Rubinsztein, Autophagy induction rescues toxicity mediated by proteasome inhibition, Neuron (2007), http://dx.doi.org/10.1016/j.neuron.2007. 06.005. Neuron ScienceDirect.com.
27. U. Pandey, Z. Nie, Y. Batlevi, B. McCray, HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS: Abstract: Nature, Nature. 447 (2007) 859-863.
28. K.T. Bush, A.L. Goldberg, S.K. Nigam, Proteasome inhibition leads to a heatshock response, induction of endoplasmic reticulum chaperones, and thermotolerance, J. Biol. Chem. 272 (1997) 9086-9092.
29. E.H.J. Yew, N.S. Cheung, M.S. Choy, R.Z. Qi, A.Y.-W. Lee, Z.F. Peng, et al., Proteasome inhibition by lactacystin in primary neuronal cells induces both potentially neuroprotective and pro-apoptotic transcriptional responses: a microarray analysis, J. Neurochem. 94 (2005) 943-956.
30. M.S. Choy, M.J. Chen, J. Manikandan, Z.F. Peng, A.M. Jenner, A.J. Melendez, et al., Up-regulation of endoplasmic reticulum stress-related genes during the early phase of treatment of cultured cortical neurons by the proteasomal inhibitor lactacystin, J. Cell. Physiol. 226 (2011) 494-510.
31. F.S. Adams, F.G. La Rosa, S. Kumar, J. Edwards-Prasad, S. Kentroti, A. Vernadakis, et al., Characterization and transplantation of two neuronal cell lines with dopaminergic properties, Neurochem. Res. 21 (1996) 619-627.
32. A.F. Kisselev, A.L. Goldberg, Monitoring activity and inhibition of 26S proteasomes with fluorogenic peptide substrates, Methods Enzymol. 398 (2005) 364-378.
33. K.S. Zafar, S.H. Inayat-Hussain, D. Ross, A comparative study of proteasomal inhibition and apoptosis induced in N27 mesencephalic cells by dopamine and MG132, J. Neurochem. 102 (2007) 913-921.
34. O.H. Lowry, N.J. Rosebrough, A.L. Farr, R.J. Randall, Protein measurement with the Folin phenol reagent, J. Biol. Chem. 193 (1951) 265-275.
35. M. Bogyo, J.S. McMaster, M. Gaczynska, D. Tortorella, A.L. Goldberg, H. Ploegh, Covalent modification of the active site threonine of proteasomal beta subunits and the Escherichia coli homolog HslV by a new class of inhibitors, Proc. Natl. Acad. Sci. USA 94 (1997) 6629-6634.
36. M.E. Figueiredo-Pereira, K.A. Berg, S. Wilk, A new inhibitor of the chymotrypsin-like activity of the multicatalytic proteinase complex (20S proteasome) induces accumulation of ubiquitin-protein conjugates in a neuronal cell, J. Neurochem. 63 (2002) 1578-1581.
37. J.J.M. Hoozemans, E.S. van Haastert, P. Eikelenboom, R.A.I. de Vos, J.M. Rozemuller, W. Scheper, Activation of the unfolded protein response in Parkinson's disease, Biochem. Biophys. Res. Commun. 354 (2007) 707-711.
38. L. Qin, Z. Wang, L. Tao, Y. Wang, ER stress negatively regulates AKT/TSC/mTOR pathway to enhance autophagy, Autophagy 6 (2010) 239-247.
39. N. Mizushima, T. Yoshimori, How to interpret LC3 immunoblotting, Autophagy 3 (2007) 542-545.
40. S. Kimura, N. Fujita, T. Noda, T. Yoshimori, Monitoring autophagy in mammalian cultured cells through the dynamics of LC3, Methods Enzymol. 452 (2009) 1-12.
41. J.A. Olzmann, L. Li, L.S. Chin, Aggresome formation and neurodegenerative diseases: therapeutic implications, Curr. Med. Chem. 15 (2008) 47-60.
42. K.S.P. McNaught, P. Shashidharan, D.P. Perl, P. Jenner, C.W. Olanow, Aggresomerelated biogenesis of Lewy bodies, Eur. J. Neurosci. 16 (2002) 2136-2148.
43. J.A. Johnston, C.L. Ward, R.R. Kopito, Aggresomes: a cellular response to misfolded proteins, J. Cell Biol. 143 (1998) 1883-1898.
44. T.F. Outeiro, J. Klucken, K.E. Strathearn, F. Liu, P. Nguyen, J.-C. Rochet, et al., Small heat shock proteins protect against alpha-synuclein- induced toxicity and aggregation, Biochem. Biophys. Res. Commun. 351 (2006) 631-638.
45. E.J.E. Ryu, H.P.H. Harding, J.M.J. Angelastro, O.V.O. Vitolo, D.D. Ron, L.A.L. Greene, Endoplasmic reticulum stress and the unfolded protein response in cellular models of Parkinson's disease, CORD Conf. Proc. 22 (2002) 10690- 10698.
46. A. Fribley, Focused Review: ER Stress and Cancer Proteasome Inhibitor Induces Apoptosis through Induction of Endoplasmic Reticulum Stress, Cancer Biol. Ther. 5 (2006) 745-748.
47. A. Jimbo, E. Fujita, Y. Kouroku, J. Ohnishi, N. Inohara, K. Kuida, et al., ER stress induces caspase-8 activation, stimulating cytochrome c release and caspase-9 activation, Exp. Cell Res. 283 (2003) 156-166.
48. K. Wang, Calpain and caspase: can you tell the difference?, Trends Neurosci 23 (2000) 59.
49. N. Mizushima, B. Levine, A.M. Cuervo, D.J. Klionsky, Autophagy fights disease through cellular self-digestion, Nature 451 (2008) 1069-1075.
50. K. Zhu, K. Dunner, D.J. McConkey, Proteasome inhibitors activate autophagy as a cytoprotective response in human prostate cancer cells, Oncogene 29 (2009) 451-462.
51. R. Garcia-Mata, Z. Bebok, E.J. Sorscher, E.S. Sztul, Characterization and dynamics of aggresome formation by a cytosolic Gfp-chimera, J. Cell Biol. 146 (1999) 1239-1254.
52. X. Zhang, S.-B. Qian, Chaperone-mediated hierarchical control in targeting misfolded proteins to aggresomes, Mol. Biol. Cell 22 (2011) 3277-3288.
53. J. Fortun, W.A. Dunn, S. Joy, J. Li, L. Notterpek, Emerging role for autophagy in the removal of aggresomes in Schwann cells, J. Neurosci. 23 (2003) 10672-10680.
54. J.P. Taylor, Aggresomes protect cells by enhancing the degradation of toxic polyglutamine-containing protein, Hum. Mol. Genet. 12 (2003) 749-757.
55. A. Iwata, J.C. Christianson, M. Bucci, L.M. Ellerby, N. Nukina, L.S. Forno, et al., Increased susceptibility of cytoplasmic over nuclear polyglutamine aggregates to autophagic degradation, Proc. Natl. Acad. Sci. USA 102 (2005) 13135-13140.
56. C.I. Holmberg, K.E. Staniszewski, K.N. Mensah, A. Matouschek, R.I. Morimoto, Inefficient degradation of truncated polyglutamine proteins by the proteasome, EMBO J. 23 (2004) 4307-4318.
57. P. Venkatraman, R. Wetzel, M. Tanaka, N. Nukina, A.L. Goldberg, Eukaryotic proteasomes cannot digest polyglutamine sequences and release them during degradation of polyglutamine-containing proteins, Mol. Cell 14 (2004) 95- 104.